157 related articles for article (PubMed ID: 25824138)
21. The association between malignant melanoma and noncutaneous malignancies.
Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
[TBL] [Abstract][Full Text] [Related]
22. Increased risk of second cancer among patients with ovarian borderline tumors.
Bouchardy C; Fernandez S; Merglen A; Usel M; Fioretta G; Rapiti E; Schubert H; Pelte MF; Chappuis PO; Vlastos G
Gynecol Oncol; 2008 May; 109(2):210-4. PubMed ID: 18377966
[TBL] [Abstract][Full Text] [Related]
23. The Risk of Second Primary Colorectal Adenocarcinomas Is Not Increased among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Nationwide Population-Based Study.
Stemann Lau T; Dam G; Jepsen P; Grønbæk H; Krogh K; Gregersen T
Neuroendocrinology; 2018; 107(3):280-283. PubMed ID: 30092588
[TBL] [Abstract][Full Text] [Related]
24. [Secondary malignant neoplasms in patients with breast cancer].
Dörffel WV; Reitzig P; Dörffel Y; Possinger K
Zentralbl Gynakol; 2000; 122(8):419-27. PubMed ID: 11005133
[TBL] [Abstract][Full Text] [Related]
25. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET
JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769
[TBL] [Abstract][Full Text] [Related]
26. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
Jain KS; Sikora AG; Baxi SS; Morris LG
Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
[TBL] [Abstract][Full Text] [Related]
27. Risk of second primary malignancies in survivors of pancreatic neuroendocrine neoplasms from 2000 to 2018.
Yang Z; Liu L; Leng K; Shi G
J Gastroenterol Hepatol; 2023 Sep; 38(9):1474-1484. PubMed ID: 37114675
[TBL] [Abstract][Full Text] [Related]
28. Male Breast Cancer as a Second Primary Cancer: Increased Risk Following Lymphoma.
Farr DE; Thomas A; Khan SA; Schroeder MC
Oncologist; 2017 Aug; 22(8):895-900. PubMed ID: 28487463
[TBL] [Abstract][Full Text] [Related]
29. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
Spanogle JP; Clarke CA; Aroner S; Swetter SM
J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
[TBL] [Abstract][Full Text] [Related]
30. [Second primary malignancy among cancer survivors - epidemiology, prognosis and clinical relevance].
Grundmann RT; Meyer F
Zentralbl Chir; 2012 Dec; 137(6):565-74. PubMed ID: 22426967
[TBL] [Abstract][Full Text] [Related]
31. Increased risk of breast cancer development after diagnosis of salivary gland tumour.
In der Maur CD; Klokman WJ; van Leeuwen FE; Tan IB; Rutgers EJ; Balm AJ
Eur J Cancer; 2005 Jun; 41(9):1311-5. PubMed ID: 15939266
[TBL] [Abstract][Full Text] [Related]
32. Risk of Second Primary Malignancies in Lung Cancer Survivors - The Influence of Different Treatments.
Su VY; Liu CJ; Chen YM; Chou TY; Chen TJ; Yen SH; Chiou TJ; Liu JH; Hu YW
Target Oncol; 2017 Apr; 12(2):219-227. PubMed ID: 27766477
[TBL] [Abstract][Full Text] [Related]
33. Second neoplasms after invasive and borderline ovarian cancer.
Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
[TBL] [Abstract][Full Text] [Related]
34. Trends of Second Primary Malignancy in Patients with Thyroid Cancer: A Population-Based Cohort Study in Israel.
Izkhakov E; Barchana M; Liphshitz I; Silverman BG; Stern N; Keinan-Boker L
Thyroid; 2017 Jun; 27(6):793-801. PubMed ID: 28338430
[TBL] [Abstract][Full Text] [Related]
35. The incidence and risk factors of metachronous colorectal cancer: an indication for follow-up.
Mulder SA; Kranse R; Damhuis RA; Ouwendijk RJ; Kuipers EJ; van Leerdam ME
Dis Colon Rectum; 2012 May; 55(5):522-31. PubMed ID: 22513430
[TBL] [Abstract][Full Text] [Related]
36. Multiple malignant tumors.
Chirila DN; Turdeanu NA; Constantea NA; Coman I; Pop T; Popp RA; Balacescu O; Vesa SC; Ciuce C
Chirurgia (Bucur); 2013; 108(4):498-502. PubMed ID: 23958092
[TBL] [Abstract][Full Text] [Related]
37. Association between colorectal cancer and urologic cancers.
Calderwood AH; Huo D; Rubin DT
Arch Intern Med; 2008 May; 168(9):1003-9. PubMed ID: 18474765
[TBL] [Abstract][Full Text] [Related]
38. High constant incidence of second primary colorectal cancer.
Levi F; Randimbison L; Blanc-Moya R; Maspoli-Conconi M; Rosato V; Bosetti C; La Vecchia C
Int J Cancer; 2013 Apr; 132(7):1679-82. PubMed ID: 22903312
[TBL] [Abstract][Full Text] [Related]
39. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
Shah BK; Khanal A
Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
[TBL] [Abstract][Full Text] [Related]
40. Pituitary adenomas in northern Sweden: a study on therapy choices and the risk of second primary tumours.
Norberg L; Johansson R; Rasmuson T
Clin Endocrinol (Oxf); 2008 May; 68(5):780-5. PubMed ID: 17980004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
